Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptors

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 7, 2006, Pages 1588-1595

  Zarei, S ^a   Frieden, M ^a   Rubi, B ^a   Villemin, P ^a   Gauthier, B R ^a   Maechler, P ^a   Vischer, Ulrich M ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Centre Médical Universitaire   (Switzerland)

Author keywords

Dopamine; Endothelial cells; Exocytosis; Histamine; von Willebrand factor

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADENOSINE; ADRENALIN; CALCIUM; CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; HISTAMINE; PD 168077; QUINPIROLE; THROMBIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; CYTOSOL; ENDOTHELIUM CELL; EXOCYTOSIS; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN;

AORTA; CELLS, CULTURED; DOPAMINE; DOPAMINE AGONISTS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXOCYTOSIS; HISTAMINE; HUMANS; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; SIGNAL TRANSDUCTION; UMBILICAL VEINS; VON WILLEBRAND FACTOR;

EID: 33745243697     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01998.x     Document Type: Article

References (42)

1. Vischer UM, de Moerloose P. Willebrand factor: From cell biology to the clinical management of von Willebrand's disease. Crit Rev Oncol Hematol 1999; 30: 93-109.
2. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-24.
3. Nichols TC, Samama CM, Bellinger DA, Roussi J, Reddick RL, Bonneau M, Read MS, Bailliart O, Koch GG, Vaiman M, et al. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: Effect on arterial thrombosis in chimeras. Proc Natl Acad Sci USA 1995; 92: 2455-9.
4. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol 1982; 95: 355-60.
5. Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Juhan-Vague I. Endothelial cell markers and the risk of coronary heart disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 2004; 109: 1343-8.
6. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995; 332: 635-41.
7. Loesberg C, Gonsalves MD, Zandbergen J, Willems C, van Aken WG, Stel HV, Van Mourik JA, De Groot PG. The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim Biophys Acta 1983; 763: 160-8.
8. 2+ asssociated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1. J Clin Invest 1987; 79: 600-8.
9. Birch KA, Pober JS, Zavoico GB, Means AR, Ewenstein BM. Calcium/ calmodulin transduces thrombin-stimulated secretion: Studies in intact and minimally permeabilized human umbilical vein endothelial cells. J Cell Biol 1992; 118: 1501-10.
10. Vischer UM, Wollheim CB. Epinephrine induces von Willebrand factor release from cultured endothelial cells: Involvement of cyclic AMP-dependent signalling in exocytosis. Thromb Haemost 1997; 77: 1182-8.
11. 2+ and cyclic adenosine monophosphate-dependent signaling in endothelial exocytosis. Blood 1998; 91: 118-27.
12. Vischer UM, Lang U, Wollheim CB. Autocrine regulation of endothelial exocytosis: Von Willebrand factor release is induced by prostacyclin in cultured endothelial cells. FEBS Lett 1998; 424: 211-5.
13. Hegeman RJ, van den Eijnden-Schrauwen Y, Emeis JJ. Adenosine 3′: 5′-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Thromb Haemost 1998; 79: 853-8.
14. Kaufmann JE, Oksche A, Wollheim CB, Gunther G, Rosenthal W, Vischer UM. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest 2000; 106: 107-16.
15. Matsushita K, Morrell CN, Cambien B, Yang SX, Yamakuchi M, Bao C, Hara MR, Quick RA, Cao W, O'Rourke B, Lowenstein JM, Pevsner J, Wagner DD, Lowenstein CJ. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 2003; 115: 139-50.
16. Matsushita K, Morrell CN, Lowenstein CJ. Sphingosine 1-phosphate activates Weibel-Palade body exocytosis. Proc Natl Acad Sci U S A 2004; 101: 11483-7.
17. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 2003; 228: 134-42.
18. Sampaio-Maia B, Serrao MP, Soares-da-Silva P. Regulatory pathways and uptake of L-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells. Am J Physiol Cell Physiol 2001; 280: C333-42.
19. Hardebo JE, Falck B, Owman C. A comparative study on the uptake and subsequent decarboxylation of monoamine precursors in cerebral microvessels. Acta Physiol Scand 1979; 107: 161-7.
20. Basu S, Dasgupta PS. Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 2000; 102: 113-24.
21. Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 2001; 7: 569-74.
22. Sarkar C, Chakroborty D, Mitra RB, Banerjee S, Dasgupta PS, Basu S. Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells. Am J Physiol Heart Circ Physiol 2004; 287: H1554-60.
23. Berger SP, Hunger M, Yard BA, Schnuelle P, Van Der Woude FJ. Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitro. Kidney Int 2000; 58: 2314-9.
24. Sookhai S, Wang JH, Winter D, Power C, Kirwan W, Redmond HP. Dopamine attenuates the chemoattractant effect of interleukin-8: A novel role in the systemic inflammatory response syndrome. Shock 2000; 14: 295-9.
25. Callier S, Snapyan M, Le Crom S, Prou D, Vincent JD, Vernier P. Evolution and cell biology of dopamine receptors in vertebrates. Biol Cell 2003; 95: 489-502.
26. Oak JN, Oldenhof J, Van Tol HH. The dopamine D(4) receptor: One decade of research. Eur J Pharmacol 2000; 405: 303-27.
27. 2+ increases in rat lactotroph cells. Evidence of a dual mechanism of action. J Biol Chem 1987; 262: 13920-7.
28. Huber D, Cramer EM, Kaufmann JE, Meda P, Masse JM, Kruithof EK, Vischer UM. Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo. Blood 2002; 99: 3637-45.
29. Moreland RB, Nakane M, Donnelly-Roberts DL, Miller LN, Chang R, Uchic ME, Terranova MA, Gubbins EJ, Helfrich RJ, Namovic MT, El-Kouhen OF, Masters JN, Brioni JD. Comparative pharmacology of human dopamine D(2)-like receptor stable cell lines coupled to calcium flux through Galpha(qo5). Biochem Pharmacol 2004; 68: 761-72.
30. Glase SA, Akunne HC, Georgic LM, Heffner TG, MacKenzie RG, Manley PJ, Pugsley TA, Wise LD. Substituted [(4-phenylpiperazinyl)-methyl]benzamides: Selective dopamine D4 agonists. J Med Chem 1997; 40: 1771-2.
31. Neumeyer JL, Kula NS, Bergman J, Baldessarini RJ. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur J Pharmacol 2003; 474: 137-40.
32. Huff RM. Signal transduction pathways modulated by the D2 subfamily of dopamine receptors. Cell Signal 1996; 8: 453-9.
33. Lang J, Nishimoto I, Okamoto T, Regazzi R, Kiraly C, Weller U, Wollheim CB. Direct control of exocytosis by receptor-mediated activation of the heterotrimeric GTPases Gi and G(o) or by the expression of their active G alpha subunits. EMBO J 1995; 14: 3635-44.
34. Ullrich S, Wollheim CB. GTP-dependent inhibition of insulin secretion by epinephrine in permeabilized RINm5F cells. Lack of correlation between insulin secretion and cyclic AMP levels. J Biol Chem 1988; 263: 8615-20.
35. Zhang WP, Ouyang M, Thomas SA. Potency of catecholamines and other L-tyrosine derivatives at the cloned mouse adrenergic receptors. Neuropharmacology 2004; 47: 438-49.
36. Dinerstein RJ, Vannice J, Henderson RC, Roth LJ, Goldberg LI, Hoffmann PC. Histofluorescence techniques provide evidence for dopamine-containing neuronal elements in canine kidney. Science 1979; 205: 497-9.
37. Krimer LS, Muly III EC, Williams GV, Goldman-Rakic PS. Dopaminergic regulation of cerebral cortical microcirculation. Nat Neurosci 1998; 1: 286-9.
38. Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: A case-control study. Lancet 2000; 356: 1219-23.
39. Herrmann N, Mamdani M, Lanctot KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004; 161: 1113-5.
40. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999; 27: 639-60.
41. Schaub M, Ploetz CJ, Gerbaulet D, Fang L, Kranich P, Stadlbauer TH, Goettman U, Yard BA, Braun C, Schnuelle P, van der Woude FJ. Effect of dopamine on inflammatory status in kidneys of brain-dead rats. Transplantation 2004; 77: 1333-40.
42. Schnuelle P, Lorenz D, Mueller A, Trede M, Van Der Woude FJ. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int 1999; 56: 738-46.